The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program.
 
Sylvie Rottey
Research Funding - Janssen (Inst)
 
Charles Van Praet
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; Ipsen
 
Fransien Van Hende
No Relationships to Disclose
 
Gino Pelgrims
No Relationships to Disclose
 
Wim Demey
No Relationships to Disclose
 
Filip Van Aelst
No Relationships to Disclose
 
Wim Wynendaele
No Relationships to Disclose
 
Thierry Gil
No Relationships to Disclose
 
Peter Schatteman
No Relationships to Disclose
 
Bertrand Filleul
No Relationships to Disclose
 
Denis C. C. Schallier
No Relationships to Disclose
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - Boehringer Ingelheim; Merck Sharp & Dohme; Pfizer
Research Funding - Bayer; Novartis; Sanofi
 
Dirk L. Schrijvers
No Relationships to Disclose
 
Els Grieta Everaert
No Relationships to Disclose
 
Lionel A. D'Hondt
No Relationships to Disclose
 
Patrick Werbrouck
No Relationships to Disclose
 
Joanna Vermeij
No Relationships to Disclose
 
Jeroen Mebis
No Relationships to Disclose
 
Marylene Clausse
No Relationships to Disclose
 
Nicolaas Lumen
Research Funding - Janssen-Ortho (Inst)